Skip to main content
1–6 Jun 2025
Taipei International Convention Center (TICC)
Asia/Taipei timezone

Magnetic field control in the MedAustron synchrotron

THPM001
5 Jun 2025, 15:30
2h
Exhibiton Hall A _Magpie (TWTC)

Exhibiton Hall A _Magpie

TWTC

Poster Presentation MC6.A28 Medical Applications Thursday Poster Session

Speaker

Thomas Margreiter (EBG MedAustron GmbH)

Description

MedAustron, a synchrotron-based ion therapy centre in Austria, is focused on enhancing cancer treatment performance. A key improvement opportunity lies in the regulation of the main ring bending dipoles, which currently require time-consuming procedures to ensure reproducibility and reliability of the associated magnetic fields (B-Fields). Other therapy centres globally address this through a traditional B-train or similar systems to regulate on the B-Field and mitigate parasitic effects. In contrast to that, we propose a novel approach utilising a single Hall probe measurement inside a reference magnet, fused with a magnet model to provide real-time, high accuracy estimates of the integral B-Field for regulation. This technique, combined with a tailored controller, is evaluated under typical therapy cycling conditions. The system's performance is demonstrated through metrological analysis and beam property comparisons. Most importantly, the results show the possibility of significant improvements in treatment time reduction. Ultimately, the already achievable beam position accuracy, and spill structure in the treatment rooms, enable the start of commissioning in 2025.

Region represented Europe
Paper preparation format LaTeX

Author

Thomas Margreiter (EBG MedAustron GmbH)

Co-authors

Fabien Plassard (EBG MedAustron GmbH) Dale Prokopovich (EBG MedAustron GmbH) Markus Wolf (EBG MedAustron GmbH) Laurids Adler (EBG MedAustron GmbH) Sebastien Pelletier (EBG MedAustron GmbH) Immanuel Gfall (EBG MedAustron GmbH) Michael Benedikt (European Organization for Nuclear Research)

Presentation materials

There are no materials yet.